|
|
| |
 |
|
| |
|
KEE GAD values inventions with great esteem. It emphasizes on protecting its own intellectual property (I P). It evaluates its I P needs and allocates funds for IP budgets. On sound strategy and with due diligence, IP protection is initiated; such strategies are also followed while outsourcing I P.
Publication of research results is another area of considerable interest of KEE GAD. The interest emanates from the encouragement the management for scientific activities.
|
|
Intellectual properties are getting generated. Two applications have been made by the company to protect the intellectual properties developed, viz. Probiotic assisted effective composition for delivery of drugs to the colon by oral route- Indian patent application submitted in September 2009 and Strong Immune Induction by using combination of Adenovirus type 5/type 35 vector and vaccine virus MVA vector- Indian patent application submitted in October 2008.
Two scientific papers were published by the company during 2010 and 2011.
Besides, other important research papers published by the Managing Director are also placed below: |
| |
|
| |
| 1. P. K. Ghosh, V. B. Gupta1, M. S. Rathore1, Iqbal Hussain1, Wound-healing potential of aqueous and ethanolic extracts of apamarga leaves, Int J. of Green Pharm., , V-5, Issue-1 (Jan-Mar 2011), pp 12-15 |
 |
| 2. Prasanta Kumar Ghosh, Vipin Bihari Gupta, Bhavik Gondoliya, Mahendra Singh Rathore, Probiotic-assisted colon-specifc delivery of diclofenac sodium from guar gum matrix tablets: In vitro evaluation, Asian J. Pharmaceutics, V-4 Issue-4 (Oct-Dec 2010), pp 173-178 |
|
3. Ghosh P. K., et. al. Prospects
Of Modern Biotechnology In India In Advances In
Biopharmaceutical Technology In India, Chapter-1,
(Ed.: Eric S. Langer , Pub.: Bio Plan Associates
,Inc., Rockville, MD, USA and Society for Industrial
Microbiology, Arlington, VA, USA), Jan
2008, pp. 1-66. |
|
4. Ghosh P. K., et. al. Human granulocyte-macrophage
colony stimulating factor: The protein and its
current & emerging applications, Indian Journal
of Biotechnology; Vol. 6, Oct 2007,
pp 435-448. |
|
5.
Ghosh P. K. et. al. Sodium Hyaluronate
Of Defined Molecular Size For Treating Osteoarthritis,
Current Science Vol. 92 No. 2; Jan 2007 pp 209-212. |
|
6.
Ghosh, P. K. et. al., Recombinant HIV-1
P24 Protein: Cloning, Expression, Purification
And Use In The Development Of Elisa Kits, Current
Science, Oct 2006, Vol. 91 No.
7 pp. 913-917. |
|
7.
Ghosh, P. K. The Role Of Alliance In
Modern Biotech Industries In Developing Countries,
Current Science, Vol. 87, No. 7, Oct 2004;
pp 874-884. |
|
8.
Ghosh, P. K. et. al.; HIV Antibody Detection
Methods: Current Approaches, J. Sci. Indus. Res., 2000, 59, pp. 919-931. |
|
9.
Ghosh, P. K. et. al. Bio-Distribution
Of Fluorscented Dextran Using Novel Nano-Particles
Evading Reticuloendothelial System, International
Journal of Pharmaceutics, Volume 202, Issues 1-2,
July 2000, pp. 1-10. |
|
10.
Ghosh, P. K. et. al. Recent Advances
In Synthesis Of Modified Oligonucleotides , J.
Ind. Chem. Soc., 2000, Vol. 77,
pp. 109-132. |
|
11.
Ghosh, P. K.; Hydrophilic Polymeric Nanoparticles
As Drug Carriers, Indian Journal Of Biochemistry
And Biophysics 2000, Vol. 37;
Part 5, pp. 273-282. |
|
12.
Ghosh, P. K. Strategics For Manipulation
Of Genes In Microbes For Production Of Beta-Lactam
Antibiotics, Current Science, 76 (8), 1999,
pp. 1096-1107. |
|
13.
Ghosh, P. K. et. al. pH And Thermosensitive
Hydrogel Nano-Particles, J. Colloid Interface
Sci 206, 1998, pp. 361-368, |
|
14.Ghosh,
P. K. Transgenic Plants And Bio-Safety
Concerns In India, Current Science, 72, (3), - 1997, pp. 172-179. |
|
15.
Ghosh, P. K. Indian Experience In Commercializing
Institutionally Developed Biotechnologies, J.
of Scientific and Industrial Research, Nov
1996, pp. 860-872. |
|
16.
Ghosh, P. K. et. al. Microbial Lipases:
Production And Applications, Science Progress
(London), 79(2), 1996, pp. 119-157 |
|
17.
Ghosh, P. K. Impact Of Industrial Policy
And Trade Related Intellectual Rights On Biotech
Industries In India , J. of Scientific and Industrial
Research 54, 1995, pp. 217-230. |
|
18.
Ghosh, P. K. et. al. Production Of Therapeutic
Polypeptides Through Escherichia Coli: A Perspective,
Hindustan Antibiotic Bulletin, 30 (1-2), 1988,
pp. 1-11. |
|
|
|
|
| |
|
Kee
Pharma Limited is a well-established Delhi based
pharmaceutical company that was started in 1957
by Mr. C.R. Motihar. Today, KPL has a 300 strong
work force... more>> |
|
|
|
